Video | 04 April 2022 Why we’re asking governments to reject the leaked text on COVID-19 at the WTO COVID-19 Leena Menghaney outlines why the leaked TRIPS Waiver doesn't go anywhere near far enough in terms of addressing the development of COVID-19 treatments, vaccines and diagnostics. Read, watch, share Filter by - Any -BlogEventsExplainerFeature storyInterviewIssue briefLetterNewsletterOpinion articlePress releaseSpeechSpotlightStatementTechnical briefVideo Photograph by Christopher Lee Press release Press release | 27 April 2022 COVID-19 MSF calls on Moderna to transfer mRNA vaccine technology without further delay 4 min Photograph by Alejandra Sandoval Press release Press release | 04 April 2022 COVID-19 MSF urges governments to reject the draft COVID-19 text at WTO that would set a negative precedent 4 min Letter | 30 March 2022 COVID-19 CSO letter to EU on the reported draft text of the TRIPS Waiver negotiation Letter | 30 March 2022 COVID-19 United States of America US civil society letter to the President on COVID-19 Waiver leaked text Technical brief | 30 March 2022 COVID-19 MSF comments on the reported draft text of the TRIPS Waiver negotiation Photograph by Pirah Qasi Press release Press release | 17 March 2022 COVID-19 MSF responds to Medicines Patent Pool deal with 35 manufacturers to produce COVID-19 treatment nirmatrelvir/ritonavir 3 min Photograph by Regina Layug Rosero Press release Press release | 16 March 2022 COVID-19 MSF responds to potential compromise on the ‘TRIPS Waiver‘ 4 min Photograph by Mariana Abdalla Explainer Explainer | 08 March 2022 COVID-19 Latin America: How patents and licensing hinder access to COVID-19 treatments 3 min Load More
Photograph by Christopher Lee Press release Press release | 27 April 2022 COVID-19 MSF calls on Moderna to transfer mRNA vaccine technology without further delay 4 min
Photograph by Alejandra Sandoval Press release Press release | 04 April 2022 COVID-19 MSF urges governments to reject the draft COVID-19 text at WTO that would set a negative precedent 4 min
Letter | 30 March 2022 COVID-19 CSO letter to EU on the reported draft text of the TRIPS Waiver negotiation
Letter | 30 March 2022 COVID-19 United States of America US civil society letter to the President on COVID-19 Waiver leaked text
Technical brief | 30 March 2022 COVID-19 MSF comments on the reported draft text of the TRIPS Waiver negotiation
Photograph by Pirah Qasi Press release Press release | 17 March 2022 COVID-19 MSF responds to Medicines Patent Pool deal with 35 manufacturers to produce COVID-19 treatment nirmatrelvir/ritonavir 3 min
Photograph by Regina Layug Rosero Press release Press release | 16 March 2022 COVID-19 MSF responds to potential compromise on the ‘TRIPS Waiver‘ 4 min
Photograph by Mariana Abdalla Explainer Explainer | 08 March 2022 COVID-19 Latin America: How patents and licensing hinder access to COVID-19 treatments 3 min
